Stocks making the biggest moves after hours: Snowflake, Marvell Technology, Agilent Technologies & more

After-hours trading was driven by a broad set of earnings and guidance updates, with strong reactions to Snowflake (+33%), Agilent (+11%), Braze (-12%), and Nutanix (+3%). Several names beat estimates and/or raised outlooks, including Salesforce, Agilent, Marvell, Snowflake, Synopsys, and nCino, while Braze and American Superconductor disappointed on margins or forward expectations. Overall the tape skewed positive on company fundamentals and forward guidance, though individual stock moves were sharp and mixed.

Analysis

The cleanest signal here is not “beats vs misses,” but capex reallocation inside enterprise software. Snowflake’s large AWS commitment effectively validates that hyperscaler infrastructure remains the toll road for AI/data workloads, which is a second-order positive for AWS utilization and a negative read-across for smaller data-platform vendors that lack balance-sheet scale to pre-commit at that level. If Snowflake can lock in multi-year cloud spend and still outgrow expectations, the market will start rewarding vendors that convert product strength into committed demand, not just ARR optics.

The dispersion between names suggests margin quality is now the key differentiator. Nutanix, Agilent, and Synopsys all showed that operating leverage matters more than headline growth in this tape, while Braze and AMSC were punished for anything that hints at gross margin or demand deceleration. That creates a short-window opportunity in software where investors likely overreact to small guide changes: names with stable margins and credible full-year operating discipline should continue to compress risk premiums, while companies with weaker unit economics are vulnerable to multiple compression over the next 1-3 quarters.

Contrarian takeaway: Salesforce’s modest guide miss is less important than its higher earnings outlook, which suggests management is prioritizing profitability over top-line acceleration. That usually supports the stock in 3-6 months if macro stays stable, but near term the setup remains sensitive to any deceleration in net-new bookings or deal cycles. The broader risk is that the market has become willing to pay for AI adjacency only when paired with hard evidence of monetization; names that cannot show that bridge may keep underperforming even after otherwise solid quarters.

The most important competitive effect is on software procurement: if AWS is the winner from Snowflake’s spend commitment, adjacent data and analytics vendors may face tighter pricing pressure as hyperscalers bundle more aggressively. That can help the largest platforms but makes mid-cap software more fragile, especially where renewal cohorts roll over in the next two quarters. In hardware and life sciences, Agilent’s raise implies more budget resilience in diagnostics and lab capex, which is constructive for the broader tools group over the next 6-12 months.

Key Decisions for Investors

• Long SNOW vs short a basket of smaller data-platform peers over the next 1-3 months; the setup favors scale winners with access to committed cloud capacity, but trim if the stock re-rates above a 15-20% premium to its prior 12-month average EV/Sales without further estimate revisions.
• Buy CRM on weakness into the next 2-4 weeks; the risk/reward is asymmetric because the market is likely underweight the full-year earnings leverage story, while any booking stabilization can force a re-rating over 3-6 months.
• Short BRZE for a 1-2 quarter horizon or use put spreads; margin disappointment is a stronger negative than the in-line EPS implies, and the stock can stay pressured until the market sees two consecutive quarters of margin repair.
• Long A vs short industrial-tech or medtech laggards for a 3-6 month relative-value trade; the raise signals durable demand and pricing discipline, while downside is capped unless lab spending rolls over sharply.
• Avoid chasing AMSC strength and consider a tactical short on any bounce; guidance shortfalls in this part of the market often lead to 20-30% downside follow-through before buyers step in.